2026 and Vaccines - Pharmacist Digest

Community pharmacies can provide HPV vaccination from 2026

The Pharmacist

JULY 3, 2025

Community pharmacies will be able to provide the HPV vaccine from 2026 to those who missed out at school, according to the government’s 10-year health plan, published today.

Community Pharmacies

Community Pharmacies Vaccines Diabetes

Kindeva Drug Delivery, Emervax partner to bring less painful vaccines

Express Pharma

JANUARY 10, 2025

Combining Emervaxs emxRNA with Kindevas microneedle patch technology will allow for ease of transport and administration of the vaccine to patients all around the world, including those located in low and middle income countries.

Vaccines

Moderna’s updated COVID-19 vaccine receives positive EMA opinion

Pharma Times

JULY 28, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Moderna’s updated COVID-19 vaccine receives positive EMA opinion by John Pinching | 28th Jul 2025 | News CHMP recommends authorization for LP.8.1-targeting

Vaccines

Bharat Biotech and GSK pledge to lower malaria vaccine price under Gavi replenishment initiative

Express Pharma

JUNE 25, 2025

Bharat Biotech International (BBIL) and GSK plc have announced a joint pledge to Gavi, the Vaccine Alliance, as part of the continued global roll-out of the RTS,S malaria vaccine. The companies confirmed a phased reduction in the vaccine’s price to below USD 5 by 2028. replenishment period (2026–2030).

Vaccines

FDA Recommends 2025-2026 COVID-19 Vaccines Be Monovalent, Target LP.8.1 Strain

Pharmacy Times

MAY 27, 2025

Following a meeting of the Vaccines and Related Biological Products Advisory Committee, the FDA announced their recommendation of COVID-19 vaccines targeting LP.8.1, a strain of the JN.1 1 variant that has become dominant in the US.

Vaccines

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

JUNE 27, 2025

Mary Dzhuryan is a class of 2026 PharmD candidate at the USC Alfred E. Mehrnaz Razavi Vakhshoori is a class of 2026 PharmD candidate at the USC Alfred E. The recent application was granted both priority review and orphan drug designation. Mann School of Pharmacy and Pharmaceutical Sciences in Los Angeles.

Pharmacy Technician

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Pharmacy Times

JULY 21, 2025

Fournier, BSc Key Takeaways The 2024-2025 influenza season saw unprecedented severity, with high hospitalization and outpatient visit rates due to a vaccine mismatch and dominant H1N1 and H3N2 strains. Targeted public health strategies are needed to improve vaccine access, education, and trust, particularly in underserved communities.

Pharmacy Technician

Pharmacy Technician Vaccines Immunization Immunity

Carefully Monitor Direct Oral Anticoagulant Medications

Pharmacy Times

JULY 26, 2025

1-4 About the Author Sinem Yasil is a 2026 PharmD candidate at the South College School of Pharmacy in Knoxville, Tennessee. Apixaban, edoxaban, and rivaroxaban inhibit factor Xa, while dabigatran inhibits thrombin, achieving similar anticoagulant effects. 5 A CBC provides information on an individual’s hematologic status.

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Diabetes Pharmacy Management

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Pharmacy Times

JUNE 4, 2025

USP plans to continue expanding its advanced technology footprint into an additional 8,000 square foot laboratory in 2026. The Advanced Technologies Lab is the latest of USP’s investments in advanced manufacturing technologies. Learn more about USP’s supply chain solutions.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Pharmacy Technician Compounding Pharmacies Compounding

Pharmacists Can Simplify the Vaccine Schedule

Pharmacy Times

JULY 22, 2025

RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available. RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available.

Vaccines

Vaccines Pharmacy Technician Immunization Immunity

Moving the Needle From Vaccine Hesitancy to Vaccine Acceptance

Pharmacy Times

JULY 28, 2025

Grillo, MBA, RPh Key Takeaways Vaccination has saved millions of lives, yet vaccine hesitancy remains a significant global health threat, fueled by misinformation and systemic barriers. SHOW MORE Many factors contribute to vaccine skepticism, including trust, convenience, and fear. million premature deaths.

Vaccines

Vaccines Pharmacy Technician Immunization Immunity

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Pharmacy Times

JULY 4, 2025

link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

Pharmacy Times

JULY 10, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Hospitals Compounding Pharmacies Pharmacy Management

Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice

Pharmacy Times

JULY 28, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Diabetes Compounding Pharmacies Compounding

Oveporexton Demonstrates Statistically Significant, Clinically Meaningful Improvements in Patients With NT1

Pharmacy Times

JULY 24, 2025

6 A new drug application (NDA) with the FDA and global regulators are expected to be filed by March 2026, according to the manufacturers. Impressively, over 95% of trial completers entered the ongoing long-term extension study, reflecting both tolerability and sustained interest among participants.

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Biosimilars Pharmacy Management

Sanofi to Begin Globally Shipping Beyfortus Ahead of RSV Season

Pharmaceutical Commerce

JUNE 9, 2025

Image Credit: Adobe Stock Images/Artur.com Key Takeaways Sanofi is shipping Beyfortus early to ensure strong supply for the 2025–2026 RSV season and avoid past shortages. and outperformed maternal vaccines in public health programs. Sanofi, AstraZeneca Launch Program to Mitigate Future RSV Vaccine Shortages. June 9, 2025.

Drug Pricing

Drug Pricing Vaccines Immunization Immunity

Locked in a federal stalemate, states take PBM reform into their own hands

PharmaVoice

JUNE 16, 2025

1, 2026, The healthcare giant also said the law would result in Arkansas paying more for prescription drugs. The PBM lobbying group Pharmaceutical Care Management Association also filed a suit last week, claiming Arkansas’ ban is unconstitutional and would impact accessibility due to pharmacies closing their doors.

Drug Pricing

Drug Pricing Independent Pharmacies Community Pharmacies Drug Development

Exonate to launch phase 2b trial of EXN407 for diabetic eye disease

Pharma Times

JULY 29, 2025

The CLEAR-DE trial is scheduled to begin in early 2026. The study will evaluate efficacy, dosing and safety in 140 NPDR patients across sites in Australia, the Middle East and China. The decision follows positive results from Exonate’s phase 1b/2a trial in March 2024.

Diabetes

Diabetes Vaccines

Acumen and JCR partner on brain delivery therapy for Alzheimer’s

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? Anticipated next steps involve generating preclinical candidate data packages, which will include non-human primate studies expected in early 2026. Following these outcomes, Acumen holds exclusive rights to develop up to two development candidates.

Packaging

Packaging Communication Hospitals Drug Development

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Drug Pricing

Op-Ed: Celebrate Direct-to-Career Paths and Primary Care Pharmacy Practice

Pharmacy Times

JUNE 10, 2025

Pharmacy schools are expected to graduate 8,000 student pharmacists in 2026…” [Instagram post]. North American Pharmacist Licensure Examination Passing Rates for 2022-2024 Graduates. National Association of Boards of Pharmacy. January 21, 2025. Accessed June 6, 2025. aacpharmacy. March 12, 2025. Accessed June 6, 2025.

Pharmacy Technician

Pharmacy Technician Doctor of Pharmacy Compounding Pharmacies Pharmacy Management

FDA approves KalVista’s Ekterly for hereditary angioedema

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out? KalVista will receive an upfront payment of $11m, with an additional $11m contingent upon achieving a regulatory milestone anticipated by early 2026. In April 2025, KalVista Pharmaceuticals granted Kaken Pharmaceutical the commercialisation rights for sebetralstat in Japan.

Packaging

Packaging Communication Hospitals Drug Pricing

Gilead wins positive European approval opinion for twice-yearly HIV injection

Pharmaceutical Technology

JULY 28, 2025

The WHO adds that the vaccine offers a highly effective, long-acting alternative to daily oral pills and other shorter-acting options. The injectable version has been heralded as a historical breakthrough by HIV experts and charities because it offers a more accessible option for patients.

Packaging

Packaging Communication Hospitals Drug Pricing

What Pharma Manufacturers Need to Know About US Trade Policy Changes

PharmaTech

JULY 23, 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines Feliza Mirasol April 30th 2024 Podcast In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Dosage

Dosage Drug Development Vaccines Pharmaceutical Manufacturing

UK government targets manufacturing as it eyes £41bn life science sector growth

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Drug Pricing

Kling Bio and Sanofi link for antibodies and epitopes discovery

Pharmaceutical Technology

JULY 24, 2025

July 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The companies aim to gain insights that could contribute information towards designing more vaccines. We are excited to combine our expertise with Sanofi’s leadership in vaccine development to advance next-generation therapeutics and vaccines.”

Vaccines

Vaccines Packaging Communication Immunization

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

PharmaTech

JUNE 24, 2025

cancer and vaccines), and non-immunogenic applications (e.g., cancer and vaccines), and non-immunogenic applications (e.g., Several types of mRNA-based vaccines have emerged, namely non-replicating linear mRNAs (NRM), self-amplifying mRNAs (saRNAs), and circular mRNAs (circRNAs). Types of messenger RNA (mRNA)-based vaccines.

Vaccines

Vaccines Dosage Drug Development Immunization

Wockhardt has high hopes for novel antibiotic Zaynich

pharmaphorum

JUNE 6, 2025

Indian pharma group Wockhardt has completed a pre-filing meeting with the FDA and hopes to submit its new antibiotic Zaynich in the US and Europe later this year, eyeing a possible launch in fiscal 2026/27.

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars

FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? Takeda anticipates commencing commercialisation efforts for Gammagard liquid ERC in the US by 2026, with plans to follow suit in the European Union (EU) by 2027. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

Packaging

Packaging Communication Hospitals Drug Pricing

Vertex and NHS England agree reimbursement for Alyftrek

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Vaccines

Aenova Adds Cold Chain Warehouse to Latina, Italy Site

PharmaTech

JUNE 27, 2025

Construction on the new warehouse began in early 2025, and the company expects the facility to be operational in the first quarter of 2026. Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics Cheryl Barton June 24th 2025 Article mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.

Dosage

Dosage Drug Development Vaccines Biosimilars

Sanofi to acquire Vicebio’s share capital for $1.15bn upfront

Pharmaceutical Technology

JULY 23, 2025

July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition includes vaccine candidates for respiratory syncytial virus and human metapneumovirus. These fully liquid vaccines can be provided in prefilled syringes, improving safety, ease of use and operational efficiency in healthcare settings.

Health and Personal Care Stores

Health and Personal Care Stores Vaccines Packaging Communication

Can the Tropical PRV Have Its Moment (Again?) – Not all Priority Review Vouchers are Created Alike: What the Potential Loss of the Rare Pediatric PRV Could Mean for the Tropical Disease PRV Program

FDA Law Blog: Biosimilars

FEBRUARY 4, 2025

With the current lapse in authorization, FDA may only award RPD PRVs for applications that have received an RPD designation before December 20, 2024, andunless reauthorized before thenmay not award any RPD PRVs after September 30, 2026. Below, we discuss some of its downstream impacts on the PRV landscape.

Vaccines

Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks

BioPharma Dive

JULY 16, 2025

The company expects the two moves together will result in more than $400 million in annual cost savings in 2026. In a statement Monday , Sarepta said it plans to cut approximately 36% of its staff and pause research on several drug programs. Please select at least one newsletter.

Drug Pricing

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Labelling

Health Canada extends Evkeeza approval for children with HoFH

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Vaccines

Organon drug for endometriosis falls short in mid-stage study

BioPharma Dive

JULY 2, 2025

The company had hoped to kick off Phase 3 research in 2026 and launch the medicine around 2029. Chief Executive Kevin Ali called the drug a “multibillion dollar opportunity” during the J.P. Morgan Healthcare Conference in January. Organon acquired the drug in its purchase of Forendo Pharma in 2021.

Drug Pricing

Drug Pricing Drug Development Vaccines

FDA to review MSD’s doravirine/islatravir NDA for HIV-1

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? A target action date of 28 April 2026 has been set under the Prescription Drug User Fee Act (PDUFA). Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster.

Packaging

Packaging Hospitals Communication Research Laboratories

GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. A decision by the FDA is expected in H1 2026.

Labelling

Labelling Vaccines Insurance Coverage and Processing Packaging

Antares Therapeutics gains $177m for cancer medicines development

Pharmaceutical Technology

JUNE 11, 2025

June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company intends to introduce its inaugural product candidate into clinical trials by 2026. The company is progressing several programmes, intending to introduce its inaugural product candidate into clinical trials by 2026.

Communication

Communication Hospitals Packaging Vaccines

NHC Submits Comments on CMS FY 2026 IPPS and LTCH PPS Proposed Rule

Putting Patients First Blog

JUNE 12, 2025

CMS’ proposed transitional relief for FY 2026—a one-time payment adjustment for hospitals facing wage index reductions greater than 9.75 However, while the legal rationale for the policy’s discontinuation is clear, the potential consequences for hospitals in structurally disadvantaged labor markets remain serious.

Hospitals

Hospitals Inpatient Vaccines Communication

JCR Pharma and Alexion partner on JUST-AAV gene therapy platform

Pharmaceutical Technology

JULY 9, 2025

How will RFK Jr’s American dream for vaccines play out? The financial impact of this agreement on JCR’s consolidated results for the fiscal year ending 31 March 2026 has already been included in the current earnings forecast. JUST-AAV is a proprietary platform technology that employs modified AAV vectors.

Insurance Coverage and Processing

Insurance Coverage and Processing Packaging Communication Hospitals